196 related articles for article (PubMed ID: 11453641)
1. Liver alcohol dehydrogenase is degraded by the ubiquitin-proteasome pathway.
Mezey E; Rennie-Tankersley L; Potter JJ
Biochem Biophys Res Commun; 2001 Jul; 285(3):644-8. PubMed ID: 11453641
[TBL] [Abstract][Full Text] [Related]
2. The degradation of nascent fibrinogen chains is mediated by the ubiquitin proteasome pathway.
Xia H; Redman C
Biochem Biophys Res Commun; 1999 Aug; 261(3):590-7. PubMed ID: 10441471
[TBL] [Abstract][Full Text] [Related]
3. Early degradation of paternal mitochondria in domestic pig (Sus scrofa) is prevented by selective proteasomal inhibitors lactacystin and MG132.
Sutovsky P; McCauley TC; Sutovsky M; Day BN
Biol Reprod; 2003 May; 68(5):1793-800. PubMed ID: 12606393
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin-proteasome pathway mediates intracellular degradation of apolipoprotein B.
Yeung SJ; Chen SH; Chan L
Biochemistry; 1996 Oct; 35(43):13843-8. PubMed ID: 8901527
[TBL] [Abstract][Full Text] [Related]
5. Rapid deubiquitination of nucleosomal histones in human tumor cells caused by proteasome inhibitors and stress response inducers: effects on replication, transcription, translation, and the cellular stress response.
Mimnaugh EG; Chen HY; Davie JR; Celis JE; Neckers L
Biochemistry; 1997 Nov; 36(47):14418-29. PubMed ID: 9398160
[TBL] [Abstract][Full Text] [Related]
6. Proteasome-dependent degradation of the human estrogen receptor.
Nawaz Z; Lonard DM; Dennis AP; Smith CL; O'Malley BW
Proc Natl Acad Sci U S A; 1999 Mar; 96(5):1858-62. PubMed ID: 10051559
[TBL] [Abstract][Full Text] [Related]
7. CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway.
Schubert U; Antón LC; Bacík I; Cox JH; Bour S; Bennink JR; Orlowski M; Strebel K; Yewdell JW
J Virol; 1998 Mar; 72(3):2280-8. PubMed ID: 9499087
[TBL] [Abstract][Full Text] [Related]
8. Accumulation of phosphorylated neurofilaments and increase in apoptosis-specific protein and phosphorylated c-Jun induced by proteasome inhibitors.
Masaki R; Saito T; Yamada K; Ohtani-Kaneko R
J Neurosci Res; 2000 Oct; 62(1):75-83. PubMed ID: 11002289
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of ubiquitin-proteasome pathway activates a caspase-3-like protease and induces Bcl-2 cleavage in human M-07e leukaemic cells.
Zhang XM; Lin H; Chen C; Chen BD
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):127-33. PubMed ID: 10229667
[TBL] [Abstract][Full Text] [Related]
10. Calpain involvement in calphostin C-induced apoptosis.
Spinedi A; Oliverio S; Di Sano F; Piacentini M
Biochem Pharmacol; 1998 Dec; 56(11):1489-92. PubMed ID: 9827582
[TBL] [Abstract][Full Text] [Related]
11. 1,25-Dihydroxyvitamin D3 increases nuclear vitamin D3 receptors by blocking ubiquitin/proteasome-mediated degradation in human skin.
Li XY; Boudjelal M; Xiao JH; Peng ZH; Asuru A; Kang S; Fisher GJ; Voorhees JJ
Mol Endocrinol; 1999 Oct; 13(10):1686-94. PubMed ID: 10517670
[TBL] [Abstract][Full Text] [Related]
12. The proteasome participates in degradation of mutant alpha 1-antitrypsin Z in the endoplasmic reticulum of hepatoma-derived hepatocytes.
Teckman JH; Burrows J; Hidvegi T; Schmidt B; Hale PD; Perlmutter DH
J Biol Chem; 2001 Nov; 276(48):44865-72. PubMed ID: 11577074
[TBL] [Abstract][Full Text] [Related]
13. Sepsis-induced increase in muscle proteolysis is blocked by specific proteasome inhibitors.
Hobler SC; Tiao G; Fischer JE; Monaco J; Hasselgren PO
Am J Physiol; 1998 Jan; 274(1):R30-7. PubMed ID: 9458895
[TBL] [Abstract][Full Text] [Related]
14. [Effect of EGF on ubiquitination and proteasome-dependent degradation of phospholipase C gamma1 in A431 cells].
Evdonin AL; Tsupkina NV; Nikol'skiĭ NN; Medvedeva ND
Tsitologiia; 2003; 45(10):1013-8. PubMed ID: 14989173
[TBL] [Abstract][Full Text] [Related]
15. Presecretory degradation of apolipoprotein [a] is mediated by the proteasome pathway.
White AL; Guerra B; Wang J; Lanford RE
J Lipid Res; 1999 Feb; 40(2):275-86. PubMed ID: 9925657
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E in macrophages and hepatocytes is eegraded via the proteasomal pathway.
Wenner C; Lorkowski S; Engel T; Cullen P
Biochem Biophys Res Commun; 2001 Mar; 282(2):608-14. PubMed ID: 11401504
[TBL] [Abstract][Full Text] [Related]
17. Involvement of the ubiquitin/proteasome system in sorting of the interleukin 2 receptor beta chain to late endocytic compartments.
Rocca A; Lamaze C; Subtil A; Dautry-Varsat A
Mol Biol Cell; 2001 May; 12(5):1293-301. PubMed ID: 11359922
[TBL] [Abstract][Full Text] [Related]
18. Degradation of the inducible cAMP early repressor (ICER) by the ubiquitin-proteasome pathway.
Folco EJ; Koren G
Biochem J; 1997 Nov; 328 ( Pt 1)(Pt 1):37-43. PubMed ID: 9359831
[TBL] [Abstract][Full Text] [Related]
19. In vivo ubiquitination and proteasome-mediated degradation of p53(1).
Maki CG; Huibregtse JM; Howley PM
Cancer Res; 1996 Jun; 56(11):2649-54. PubMed ID: 8653711
[TBL] [Abstract][Full Text] [Related]
20. Synphilin-1 degradation by the ubiquitin-proteasome pathway and effects on cell survival.
Lee G; Junn E; Tanaka M; Kim YM; Mouradian MM
J Neurochem; 2002 Oct; 83(2):346-52. PubMed ID: 12423244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
